7 ASX 200 shares with reaffirmed buy ratings this week

S&P/ASX 200 Index (ASX: XJO) shares are 0.25% higher at 9,075.3 points on Thursday.

As earnings season continues, brokers have signalled continuing confidence in several ASX 200 shares this week.

Let’s take a look.

The Zip share price is $2.85, up 10.5% today and down 6% over 12 months.

Citi reiterated its buy rating on Zip shares after the buy now, pay later company’s FY26 report.

The broker has a price target of $3.55.

This implies potential capital gains of 25% ahead for the ASX 200 financial share.

The BHP share price is $65.26, up 2.4% today and up 56% over 12 months.

Morgan Stanley renewed its buy rating on BHP shares after the miner’s FY26 report.

The broker increased its 12-month price target from $67 to $67.50.

This suggests a potential 3% upside ahead.

The Hub24 share price is $76.22, down 4.4% today and down 27% over 12 months.

Morgan Stanley renewed its buy rating on Hub24 shares after the company’s FY26 report.

The broker has a $121 target, which suggests a potential 58% upside ahead.

The Santos share price is $8.45, up 1.7% today and up 12% over 12 months.

Citi reaffirmed its buy rating on the ASX 200 energy share yesterday.

This followed Santos’ 1H FY26 report.

The broker raised its 12-month target from $8.30 to $9.

This suggests a potential 6% upside ahead.

Coles Group Ltd (ASX: COL)

The Coles share price is $23.07, down 0.9% today and up 8% over 12 months.

Citi renewed its buy rating on Coles shares this week.

The broker has a $23 target on the ASX 200 consumer staples share.

This implies the stock is already fully valued.

Coles will report its FY26 earnings next Tuesday, 25 August.

The Telix Pharmaceuticals share price is $17.54, up 4% today and up 4% over 12 months.

Bell Potter reiterated its buy call on the ASX 200 healthcare share after reviewing the company’s 1H FY26 report.

The broker has a price target of $19, which implies a potential 8% upside ahead.

The IAG share price is $7.86, down 3.6% today and down 14% over 12 months.

Jefferies renewed its buy rating on IAG shares after reviewing the insurer’s FY26 report.

The broker shaved its 12-month price target from $9.45 to $9.25.

This suggests a potential 17% upside ahead.